CLASSIFICATION: SYNTHETIC PEPTIDE (REPAIR & RECOVERY) ACTIVE SUBSTANCE: THYMOSIN BETA-4 FORM: 2 ML VIAL x 5 MG (LYOPHILIZED POWDER) ACTIVE HALF-LIFE: 2.5-3 DAYS DOSAGE: MEN 7.66 MG/WEEK ACNE: NO WATER RETENTION: NO HIGH BLOOD PRESSURE (HBP): NO HEPATOTOXICITY: NO AROMATIZATION: NO MANUFACTURER: DRAGON PHARMA LABORATORY TESTED : VIEW LAB RESULTS CLASSIFICATION: NOOTROPIC PEPTIDE ACTIVE SUBSTANCE: SELANK FORM: 2 ML VIAL x 10 MG (LYOPHILIZED POWDER) ACTIVE HALF-LIFE: ~ 2-3 HOURS DOSAGE: MEN 250-500 MCG/DAY ACNE: NO WATER RETENTION: MINIMAL HIGH BLOOD PRESSURE (HBP): NO HEPATOTOXICITY: NO AROMATIZATION: NO MANUFACTURER: DRAGON PHARMA LABORATORY TESTED : VIEW LAB RESULTS CLASSIFICATION: SYNTHETIC MELANOCORTIN PEPTIDE ACTIVE SUBSTANCE: MELANOTAN 2 FORM: 2 ML VIAL x 10 MG (LYOPHILIZED POWDER) ACTIVE HALF-LIFE: ~ 3036 HOURS DOSAGE: 0.251 MG/DAY (LOADING), THEN 0.51 MG EVERY 23 DAYS (MAINTENANCE) ACNE: NO WATER RETENTION: NO HIGH BLOOD PRESSURE (HBP): NO HEPATOTOXICITY: NO AROMATIZATION: NO MANUFACTURER: DRAGON PHARMA LABORATORY TESTED : VIEW LAB RESULTS CLASSIFICATION: NOOTROPIC PEPTIDE ACTIVE SUBSTANCE: SEMAX FORM: 2 ML VIAL x 5 MG (LYOPHILIZED POWDER) ACTIVE HALF-LIFE: 2-3 HOURS DOSAGE: MEN 200-600 MCG/DAY ACNE: NO WATER RETENTION: NO HIGH BLOOD PRESSURE (HBP): NO HEPATOTOXICITY: NO AROMATIZATION: NO MANUFACTURER: DRAGON PHARMA LABORATORY TESTED : VIEW LAB RESULTS CLASSIFICATION: BODY PROTECTING COMPOUND ACTIVE SUBSTANCE: PENTADECAPEPTIDE FORM: 2 ML VIAL x 5 MG (LYOPHILIZED POWDER) ACTIVE HALF-LIFE: ~ 4-6 HOURS DOSAGE: 200-500 MCG/DAY ACNE: NOT REPORTED WATER RETENTION: NONE HIGH BLOOD PRESSURE (HBP): NO KNOWN IMPACT HEPATOTOXICITY: NONE AROMATIZATION: DOES NOT AROMATIZE MANUFACTURER: DRAGON PHARMA LABORATORY TESTED : VIEW LAB RESULTS CLASSIFICATION: PEPTIDE BLEND/HEALING & RECOVERY ACTIVE SUBSTANCES: - 5 MG THYMOSIN BETA 4 - 5 MG PENTADECAPEPTIDE FORM: 2 ML VIAL x 10 MG (LYOPHILIZED POWDER) ACTIVE HALF-LIFE: TB 500: 2-3 DAYS
"Effect of Melanotan-II on Brain Fos Immunoreactivity and Oxytocin Neuronal Activity and Secretion in Rats." Journal of Neuroendocrinology
Table 1 shows representative clinical trials and results of GLP-1RAs in liver diseases
When GLP-1 serum levels increase, secretion of insulin increases as well and reduces glucose levels in the body
Aanbevelingen voor dosering De standaarddosis L-carnitine is 500 -2000 mg per dag
confirmed an increase in skin thickness in the range of the epidermis and dermis, improved skin hydration, a significant smoothing of the skin by stimulating collagen synthesis, increased skin elasticity, a significant improvement in skin contrast and an increased production of collagen I [18,19]
